Dräger Danmark A/S: Financial statements 2012
CVR: 56523014
Source: annual report 2012, Danish Business Authority
01/01/2012 – 31/12/2012
Dräger Danmark A/S (CVR 56523014) has filed annual accounts for 2012. In 2012, the company reported a gross profit of DKK 12,452,010 and a net result of DKK 178,303. Equity in the 2012 report amounted to DKK 9,624,675. The solvency ratio was 48.6%.
- Gross Profit
- DKK 12,452,010
- Profit/Loss
- DKK 178,303
- Equity
- DKK 9,624,675
- Total Assets
- DKK 19,816,378
Official annual report
Keep an eye on Dräger Danmark A/S
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringEvents in 2012
As of March 15, 2012, Arno Wolters has joined the board of directors of Dräger Danmark A/S.
As of March 15, 2012, Marko Hagen Wittich has left the board of directors of Dräger Danmark A/S.
As of January 12, 2012, PRICEWATERHOUSECOOPERS STATSAUTORISERET REVISIONSPARTNERSELSKAB has been appointed auditor of Dräger Danmark A/S.
As of January 12, 2012, JUT NR. 2180 A/S has stepped down as auditor of Dräger Danmark A/S.
About Dräger Danmark A/S
Dräger Danmark A/S is a Danish company of the type Aktieselskab based in Herlev, founded in 1976. The company is registered under the industry Anden specialiseret engroshandel i.a.n.. The company was previously named DRÄGER SAFETY DANMARK A/S and DRAGER TEKNIK A/S. The management consists of Line Vibe, Jacob Larsen and Kent Tony Mathias Lindgren. The board consists of Thomas Engler (chair), Line Vibe and Robert Espig. The company is owned by Dräger Medical International GmbH. The company has 31 employees (2018). In 2025, the company reported a gross profit of DKK 28,966,451 and a net result of DKK 4,464,490 compared with DKK 4,071,069 the year before. Equity in the 2025 report amounted to DKK 22,773,467.